Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Shibuya, TokyoFounded 19371,976 employeesWebsite
A diversified chemical manufacturer operating under the slogan 'From Bioscience to Space.' It specializes in high-value-added products like functional lipids, DDS materials, and explosives.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Functional Chemical Products Business | 57% | ¥145.8B | ¥26.8B | 18.4% |
| Explosives and Chemical Products | 24% | ¥61.7B | ¥8.0B | 12.9% |
| Pharmaceutical and Healthcare Business | 19% | ¥49.9B | ¥15.8B | 31.7% |
Close (Oct 30, 2026)
¥2,799+2.6% (1Y)
NOF +2.6% over 1Y, 23.3pt below the industry average (59 companies, +25.8%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥258.0B | ¥47.4B | ¥40.5B | ¥399.2B | +8.2% |
| 2025FY | ¥238.3B | ¥45.3B | ¥36.5B | ¥357.2B | +7.2% |
| 2024FY | ¥222.3B | ¥42.1B | ¥34.0B | ¥341.4B | +2.1% |
| 2023FY | ¥217.7B | ¥40.6B | ¥34.0B | ¥309.4B | +13.0% |
| 2022FY | ¥192.6B | ¥35.6B | ¥26.7B | ¥289.6B | +11.6% |
| 2021FY | ¥172.6B | ¥26.6B | ¥23.3B | ¥271.5B | — |
Sources: annual securities reports, earnings releases and other public disclosures
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
